Watson Pharmaceuticals Inc.



Sort by : relevance - date - popularity
1Vote!

Watson gets FDA approval for generic Plan B

NEW YORK — Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration...

+Vote!

Watson gets FDA approval for generic Plan B

Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive.

+Vote!

Watson gets FDA approval for generic Plan B

Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive.

+Vote!

Watson gets FDA approval for generic Plan B

Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals' Plan B emergency contraceptive. The generic version is approved for prescription use only. Duramed has exclusive... Sponsored Topics: US Food and Drug Administration - Barr Pharmaceuticals - Emergency contraception - Health - United States

+Vote!

InvestorSoup.com issues In-depth Look at: WPI, EIX, SMG, SLAB, ALVR

(EMAILWIRE.COM, June 18, 2009 ) DALLAS, Texas – InvestorSoup.com announces the release of Stock Alerts covering market movers: Watson Pharmaceuticals Inc. (NYSE: WPI), Edison International (NYSE: EIX), The Scotts Miracle-Gro Co. (NYSE: SMG), Silicon Laboratories Inc. (Nasdaq: SLAB) and Alvarion...

+Vote!

Watson Pharmaceuticals Buys Arrow Group for $1.75bn

Image: Pharmer.org Watson Pharmaceuticals acquired Arrow Group for $1.75 billion in stock and cash today. The deal is the latest in a wave of pharmaceutical company mergers and acquisitions. Bloomberg has more: Watson Pharmaceuticals Inc. agreed to buy closely held Arrow Group for $1.75 billion in cash and stock, gaining more than 100 generic medicines. Watson, [...]

+Vote!

Watson to buy Arrow group for $1.75B

Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock, getting access to a promising drug candidate pipeline and new markets.

+Vote!

Watson Pharma to buy Arrow group for $1.75B

NEW YORK — Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker A...

+Vote!

Watson Pharmaceuticals to buy generic maker Arrow Group

Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.

+Vote!

Watson Pharma to buy Arrow group for $1.75 billion

NEW YORK -- Watson Pharmaceuticals Inc. said today it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.

+Vote!

Watson goes global with $1.75 billion Arrow deal

NEW YORK (Reuters) - Watson Pharmaceuticals Inc said on Wednesday it will buy privately held Arrow Group for $1.75 billion, clinching a long-expected deal by the U.S. generic drugmaker to expand internationally.

+Vote!

Watson Pharma to buy Arrow group for $1.75B

Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.

+Vote!

Watson Pharma to buy Arrow group for $1.75B

Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.

+Vote!

Watson to acquire Arrow Group for $1.75 billion

NEW YORK (MarketWatch) -- Watson Pharmaceuticals Inc. said Wednesday that it will acquire privately held Arrow Group for $1.75 billion in cash and stock. Watson expects the transaction to close in the second half of 2009, and be accretive to cash earnings per share in 2010 before synergies. Watson said the result will be a global pharmaceutical company with over $3 billion in revenue and commercial...

+Vote!

Stock Picks : Watson (NYSE: WPI)

This week’s hot stock from a hot sector is Watson Pharmaceuticals Inc. (WPI). Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States. Watson recently reported and earnings and provided Wall Street strong guidance for the rest of the...